'We are going to have lung cancer patients living longer and better:' A new kind of cancer treatment is about to change how we treat the disease (MRK, BMS)

New cancer treatments that harness the body's immune system are ready to go mainstream. In data presented Monday at the American Association of Cancer Research's annual meeting, cancer drugmakers showed that the use of immunotherapy in combination with other drugs did a better job of treating lung cancer than chemotherapy alone. A combination of Merck's immunotherapy drug, Keytruda, and chemotherapy cut the risk death in lung cancer patients by half. The results could massively impact...

What feeling does this article give you?

#hashtags to follow:

Monday [+]    Merck [+]    Keytruda [+]   

More #news: